HMOX1 and persistent truncus arteriosus: Therefore, this study aims to evaluate the impact of the antidiabetic DPP-4 inhibitor, Lina on TAC-induced kidney injury beyond the improvement of glycemic control and emphasize the modulatory effects on Nrf2/HO-1 and HIF-1α/CTGF/PAI-1 axis.